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Abstract
Background: Human schistosomiasis is a neglected tropical disease of great importance that remains highly
prevalent in Yemen, especially amongst rural communities. In order to investigate the genetic diversity of human
Schistosoma species, a DNA barcoding study was conducted on S. mansoni and S. haematobium in Yemen.
Methods: A cross-sectional study was conducted to collect urine and faecal samples from 400 children from five
provinces in Yemen. The samples were examined for the presence of Schistosoma eggs. A partial fragment of the
schistosome cox1 mitochondrial gene was analysed from each individual sample to evaluate the genetic diversity
of the S. mansoni and S. haematobium infections. The data was also analysed together with previous published
cox1 data for S. mansoni and S. haematobium from Africa and the Indian Ocean Islands.
Results: Overall, 31.8 % of participants were found to be excreting schistosome eggs in either the urine or faeces
(8.0 % S. mansoni and 22.5 % S. haematobium). Nineteen unique haplotypes of S. mansoni were detected and split
into four lineages. Furthermore, nine unique haplotypes of S. haematobium were identified that could be split into
two distinct groups.
Conclusion: This study provides novel and interesting insights into the population diversity and structure of S.
mansoni and S. haematobium in Yemen. The data adds to our understanding of the evolutionary history and
phylogeography of these devastating parasites whilst the genetic information could support the control and
monitoring of urogenital and intestinal schistosomiasis in these endemic areas.
Keywords: Schistosoma mansoni, Schistosoma haematobium, Neglected tropical diseases, Molecular epidemiology,
DNA barcoding, Genetic diversity, Evolution, Yemen
Background
Schistosomiasis is one of the most prevalent neglected
tropical diseases (NTDs) in the tropics and subtropics,
where it is endemic in 76 countries. It is estimated that
240 million people are infected, 85 % of which reside in
Africa, with nearly 700 million people estimated to be at
risk of infection [1–3]. Three Schistosoma species, namely
Schistosoma mansoni, S. haematobium and S. japonicum
are considered medically important to humans because of
their high prevalence rates, pathogenicity and vast distri-
bution [2, 4]. Praziquantel (PZQ) continues to be the drug
of choice in terms of controlling the disease in areas with
high schistosomiasis morbidity [3, 5]. However, the para-
sites response to the drug requires suitable monitoring as
part of current mass drug administration (MDA) pro-
grammes [6].
Pathogen genetic diversity can be affected by many
factors, including environmental influence, host im-
munity and the large-scale administration of treatment
[7–14]. High genetic diversity in a parasite population
may contribute to the development of drug resistant spe-
cies and thus cause the emergence of unsusceptible geno-
types, although such a correlation is still considered to be
* Correspondence: halmekhlafi@yahoo.com; b.webster@nhm.ac.uk
1Department of Parasitology, Faculty of Medicine, University of Malaya, 50603
Kuala Lumpur, Malaysia
5Parasites and Vectors Division, Department of Life Sciences, Natural History
Museum, Cromwell Road, London SW7 5BD, UK
Full list of author information is available at the end of the article
© 2015 Sady et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sady et al. Parasites & Vectors  (2015) 8:544 
DOI 10.1186/s13071-015-1168-8
somehow controversial [15]. Several studies have investi-
gated the systematics, genetic diversity and structure of
Schsitosoma species by analysis of the mitochondrial (mt)
cytochrome oxidase subunit I (cox1) gene [15–20].
Globally, partial cox1 analysis of S. mansoni isolates has
shown a geographical separation into five main groups or
lineages, with the most extensive genetic diversity being
found in the old world, particularly in East Africa [15, 21].
In contrast partial cox1 molecular data of S. haematobium
showed extremely low levels of genetic diversity within
and between S. haematobium populations and divided
them into two distinct groups; Group 1 was centred
around a highly common, persistent and widespread
mainland African haplotype (H1) and Group 2 was more
diverse and unique to the Indian Ocean Islands [19, 22].
Yemen has been reported to have the highest prevalence
of S. mansoni and S. haematobium in Middle Eastern
regions [23]. Despite sustained efforts to control the dis-
ease, recent studies have shown a high rate of infection
among children in rural areas, whilst also identifying pre-
viously unknown transmission foci [24–28]. Despite nu-
merous epidemiological studies on schistosomiais in
Yemen, molecular analysis of the S. haematobium and S
mansoni populations has not yet been done. This study
was conducted in order to investigate the mtcox1 variation
of human Schistosoma species in Yemen, enabling a better
understanding of the genetic diversity and molecular
epidemiology of human schistosome in Yemen and the
relationship with other geographical populations.
Methods
Ethical statement
This study was conducted in Yemen between January
and July 2012, after receiving approval from the Medical
Ethics Committee of the University of Malaya Medical
Centre (Ref. no: 968.4). The study protocol was also ap-
proved by the Yemen National Schistosomiasis Control
Program (NSCP), the Ministry of Health and Population,
as well as Hodeidah University, Yemen.
The parents or guardians and their children were met
in their villages where they were invited to participate in
this study. A clear explanation of the study’s objectives
and methods were given prior to data collection, with
written signed or thumb-printed (for those who are
illiterate) consent having been obtained from the parents
on behalf of their children, and these procedures were
approved by the Medical Ethics Committee of the
University of Malaya Medical Centre. The children and
their parents were informed that they could withdraw
from the study at any stage without any consequences
and without citing reasons for doing so.
Each participant who confirmed to be infected with
schistosomiasis was treated with a single dose of
40 mg/kg body weight of PZQ under observation of the
researcher and participating medical officer (Direct
Observed Therapy).
Study design, area and population
An exploratory, cross sectional study was carried out
among a cohort of children aged ≤ 15 years, all of whom
were living in rural communities in Yemen. Data were col-
lected in a period of 7 months from January to July 2012.
Overall, 250 households were randomly selected from 20
villages in Taiz, Ibb, Dhamar, Sana’a and Hodiedah prov-
inces. In each province, two rural districts were randomly
selected from the available district list and then two
villages within the selected districts were considered in
collaboration with the Schistosomiasis Control Project
office in each province (Fig. 1). The districts were Mosa
and Almafer (Taiz), Alsabrah and Alodien (Ibb), Otmah
and Gabal al sharq (Dhamar), Alhemah and Manakhah
(Sana’a), and Gabal Ras and Bora (Hodiedah). The
five provinces are well known as being endemically
plagued with both urinary and intestinal schistosomiasis
based on information gathered by the Yemen National
Schistosomiasis Control Program (NSCP). Of the 632
children who agreed to participate in this study, 400 chil-
dren successfully submitted the required stool and urine
specimens, gave their signed consent and completed the
questionnaire (77 from Sana’a, 76 from Taiz, 69 from Ibb,
85 from Hodiedah and 93 from Dhamar).
A description of the study area and population details
have been published previously [28].
Parasitological surveys
Faecal and urine samples were collected separately into
individual clearly labelled 100 ml clean containers with
wide mouths and screw-cap lids. The samples were col-
lected between 10 am and 2 pm as this is the maximum
egg excretion period that was reported by Gray et al.
[29]. The containers were placed into zipped plastic bags
before being transported (within 6 h of collection) in
suitable cool boxes with a temperature of 4–6 °C for
subsequent examination at the nearest health centre
laboratory. The samples were further subjected to
microscopic examination to identify the presence and in-
tensity of schistosome eggs. For S. mansoni 1 g of each
faecal sample was examined using formalin ether sedi-
mentation and Kato-Katz techniques [30, 31]. S. haema-
tobium urine samples were examined for haematuria
using a dipstick test (Chuncheon, Korea), and then 10
mls of the urine samples were filtered using nucleopore
membranes and the filtrate was examined for schisto-
some eggs [32]. For molecular analysis about 1 g of each
stool sample was preserved in 70 % ethanol (DNA-
friendly) before being refrigerated [33] and about 1 ml of
sediment from each urine sample was preserved in 70 %
ethanol before being refrigerated [34]. The preserved
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specimens were transferred to the Department of Parasit-
ology, Faculty of Medicine, University of Malaya, Kuala
Lumpur and kept refrigerated for molecular processing.
DNA preparation
Prior to DNA extraction each ethanol-fixed stool and
urine sample was put in a 2 ml microfuge tube and
washed three times in MilliQ H2O buffer. The samples
were then centrifuged for 5 min at 2000 rpm to remove
the ethanol. Lysis buffer from the DNeasy Blood &
Tissue Kit and QIAamp DNA Stool Mini Kit (QIAgen,
Hilden, Germany) was then added to each urine and fae-
cal sample. Genomic DNA was extracted from each
stool and urine sample according to the manufacturer’s
instructions (DNeasy Blood & Tissue Kit and QIAamp
DNA Stool Mini Kit (QIAgen, Hilden, Germany).
Molecular analysis
To detect schistosome DNA in each urine and stool sam-
ple, a multiplex schistosome specific PCR was performed
using the DNA extracted. The schistosome partial cox1
mitochondrial DNA (mtDNA) region was amplified using
a universal forward primer ShbmF (5′-TTTTTTGGTCA
TCCTGAGGTGTAT-3′) with three species-specific re-
verse primers, ShR (5′-TGATAATCAATGACCCTGCA
ATAA-3′) for S. haeamtobium, SbR (5′-CACAGGATCA
GACAAACGAGTACC-3′) for S. bovis [35] and SmR
(5′-TGCAGATAAAGCCACCCCTGTG-3′) for S. man-
soni [36]. PCR amplification was performed in 25 μl
reactions containing 12.5 μl master mix (QIAGEN Multi-
plex PCR-HotStarTaq DNA Polymerase), 1.6 μM of the
universal forward primer (ShbmF), 0.8 μM of each of the
three reverse primers (ShR, SbR and SmR) and 2 μl of
DNA (~103.7 ng/μl from urine samples) and 255.7 ng/μl
from faecal samples).
PCR cycling conditions were subjected to an initial de-
naturing step of 95 °C for 3 min, followed by 30 cycles
of 94 °C for 30 s, 58 °C for 1 min 30 s and 72 °C for
1 min 30 s, with a final extension of 7 min at 72 °C.
Amplicons were visualized and sized on a 2 % agarose
Fig. 1 A geographic map showing the location of the districts and provinces involved in the study. The map was created using the Esri ArcMap
10.2.1 software
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gel stained with SYBR® Safe DNA (Invitrogen, Auckland,
New Zealand).
DNA sequencing and cox1 data analysis
PCR products were purified using the QIAquick Gel
Extraction Kit (catalog. no. 28104; QIAGEN, Hilden,
Germany) and sequenced in both directions using a dilu-
tion of the universal forward primer and the specific re-
verse primer that corresponded to the species specific
amplicon size (375 bp for S. mansoni, 543 bp for S. hae-
matobium). Amplicon sequences were run on an Applied
Biosystems 3730XL DNA Analyzer (Applied Biosystems,
USA) according to the manufacturer’s instructions.
Purified PCR products from samples that showed
mixed chromatograms within sequence data were
cloned in the pGEM®-T Vector (Promega, USA) and
amplified in Escherichia coli JM109 competent cells.
Recombinant clones were selected from each specimen
and screened by PCR. Minipreparations of plasmid
DNA were done using the QIAprep Spin Miniprep kit
(QIAGEN, USA). Three or four clones containing in-
serts of approximately the expected size were randomly
selected for each sample and sequenced according to
the method mentioned above.
Sequence Scanner v1.0 (http://www.appliedbiosystems.
com) and BioEdit Sequence Alignment Editor Software
7.2.0 (http://www.mbio.ncsu.edu) were used to manually
view, edit and remove any sequence ambiguities. Consen-
sus sequences were aligned and any polymorphism be-
tween sequences was checked by visualisation of the
original sequence chromatograms.
Using the Basic Local Alignment Search Tool (NCBI-
BLAST), the consensus sequences were compared and
queried to sequence information on the Genbank database
to confirm the identity of the species (http://blast.ncbi.nlm.
nih.gov). S. mansoni and S. haematobium sequences were
grouped separately and aligned using Clustal W [37]. Any
identical sequences were identified and grouped to form in-
dividual haplotypes. Individual haplotype sequences were
then deposited in the Genbank (Genbank ID: 1783061)
(accession numbers: KP294279-KP294306; Tables 1 and 2).
Population genetic analysis
Haplotype sequences of S. mansoni and S. haematobium
were analysed using MEGA 5 (www.megasoftware.net).
Neighbour-joining (NJ), maximum parsimony and mini-
mum evolution algorithms using pair-wise distances cal-
culated by the Kimura-2parameter (K2P) method [38],
with a 1000 bootstrap value were used to investigate the
relationships between the haplotypes [39]. Furthermore,
a Maximum Likelihood (ML) analysis with 500 replicates
was used to investigate the topology of the trees, prior




810 819 831 846 918 921 939 948 972 978 984 988 993 999 1002 1024
Y1ISM KP294288 C C G T T T A T G G C A G G C G
Y2DSM KP294289 A . A . . . . C . . . G . A . .
Y3HSM KP294290 . . A . . . . . . . . G . A . .
Y4TSM KP294291 . . A . . . . . . A T G A A . A
Y5TSM KP294292 . . A . . . . . . A . G A A . .
Y6ISM KP294293 T . A . . . . . . A . G . A . .
Y7TSM KP294294 . . A . . . . . . A . G . A . .
Y8TSM KP294295 . . A . . . . . . . . G . A . A
Y9ISM KP294296 . . A . . . . . . . . G . A . .
Y10ISM KP294297 . . A C C A . . . A . G . A . .
Y11ISM KP294298 . . A C C A . . . . . G . A . .
Y12ISM KP294299 . . A C C A . . . . . G . A T .
Y13ISM KP294300 . . . C C A . . . . . . . . T .
Y14ISM KP294301 . . . C C A . . . . . . . . T A
Y15ISM KP294302 . . . C C A . . . . . . A . T A
Y16ISM KP294303 . . . C C A . . . . . G . . T .
Y17ISM KP294304 . . . C C A . . . A . . . . . .
Y18SSM KP294305 T T . . C G G . A . T G . A T A
Y19DSM KP294306 T T . . . G G . A A . G . A T .
aThe nucleotide location is taken from the numbering of the partial mitochondrial cox1 gene of S. mansoni (Genbank accession no. NC002545.1)
(.) which indicate nucleotides identity
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to a best model (HKY +G) being selected based on the
ML in jModeltest 0.1.1 [40].
Haplotype analysis
Nucleotide divergence was calculated for the S. mansoni
and S. haematobium haplotypes using the Juke-Cantor cor-
rection model in DnaSP V5.10 [41]. Reference sequences
from Webster et al. [15, 19, 22] were also included in the
analysis. This was done by alignment of the unique haplo-
types consensus sequences of the present study with the
indicated published reference sequences using BioEdit
Sequence Alignment Editor Software, and then refined
manually to fit with our sequences size (375 bp for S.
mansoni, 543 bp for S. haematobium). A minimum
spanning network was also generated in order to estimate
genealogical relationships among haplotypes using TCS
(http://darwin.uvigo.es/software/tcs.html) software.
Tests of selection
Selection and neutrality tests were conducted in DnaSP
V5.10 to investigate any selection in our mitochondrial
cox1 data without deviating from natural selection using
the McDonald-Kreitman and Tajima’s tests.
Results
Prevalence of human schistosomiasis
Of the 400 participants, 127 (31.8 %) were egg-positive
for schistosomiasis. Overall, 90 participants (22.5 %) had
urogenital schistosomiasis, 32 (8.0 %) had intestinal
schistosomiasis and 5 (1.3 %) were co-infected with both
S. haematobium and S. mansoni (Table 3). The highest
prevalence of schistosomiasis was reported in Hodiedah
(37.6 %), followed by Taiz (36.8 %), whereas Dhamar had
the lowest rate of prevalence (19.4 %). With regards to
schistosome species, Hodiedah had the highest preva-
lence (36.5 %) of S. haematobium infection followed by
Sana’a (33.8 %) while Ibb had the highest prevalence of
S. mansoni infection (31.9 %). Data on the prevalence,
distribution and risk factors of schistosomiasis among
the participants has been published [28].
Of the 127 egg-positive samples, schistosome cox1
amplicons and sequences were obtained from 31 stool
and 78 urine samples (Table 3). Only S. haematobium
specific (543 bp) amplicons were obtained from the
urine samples and S. mansoni specific (375 bp) amplicons
were obtained from the stool samples. On the other
hand, 3 % of stools and 13 % of urines egg-positive




740 743 827 842 875 1007 1037 1118 1163 1184 1193 1197
Y1DSH KP294279 A T T C C G T T G G T G
Y2TDISH KP294280 . . . . . . C . . . . .
Y3DSH KP294281 . . . . . . C . . A . .
Y4HSH KP294282 . . C T T . . . . A C A
Y5HSH KP294283 . . C T T . . . A A C A
Y6HSH KP294284 . . C T T A . C A A C A
Y7SSH KP294285 . C . . . . C . . . . A
Y8SSH KP294286 . C . . . . C . . . . .
Y9TSH KP294287 G . . . . . C . . . . .
aThe nucleotide location is taken from the numbering of the partial mitochondrial cox1 gene of S. haematobium (Genbank accession no. NC008074.1)
(.) which indicate nucleotides identity
Table 3 Numbers of egg-positive and PCR-positive urine and stool samples from the 5 schistosomiasis endemic areas in Yemena
Location No. examinedb Egg positive PCR positive
S. mansoni S. haematobium S. mansoni S. haematobium
N % N % N % N %
Sana’a 77 1 2.7 26 33.8 1 3.2 19 24.4
Taiz 76 8 21.6 24 31.6 9 29.0 19 24.4
Hodiedah 85 1 2.7 31 36.5 1 3.2 26 33.3
Ibb 69 22 59.5 1 1.5 15 48.4 1 1.3
Dhamar 93 5 13.5 13 14.0 5 16.1 13 16.7
Total 400 37 9.3 95 23.8 31 7.8 78 19.5
aData on the prevalence and distribution of schistosomiasis among the participants has been published [28]
bUrine and stool samples
(.) which indicate nucleotides identity
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samples were PCR-negative. These were retested several
times, but cox1 amplification remained unsuccessful.
Moreover, Schistosoma egg-negative samples were also
PCR negative.
Schistosoma mansoni population genetics
As the schistosome DNA was extracted and amplified
from whole faecal samples the DNA sequences repre-
sented the genetic profile from a pooled S. mansoni
population infecting each individual host. Mixed se-
quence chromatograms were observed at the poly-
morphic sites within the mtcox1 region amplified,
with the chromatograms giving the highest peak being
recorded as the haplotype data. These haplotypes will
therefore represent the most common haplotype
found within the pooled population but observations
of the mixed chromatograms within sequence data
show that there are many more haplotypes that could
not be clearly identified. Moreover, our selection was
confirmed by cloning and sequencing of samples that
showed mixed sequence chromatograms (5 S. mansoni
and 2 S. haematobium). Among the five localities in
Yemen, 19 unique S. mansoni cox1 haplotypes were
detected from 31 samples. Haplotype distribution var-
ied by location and the highest diversity was observed
in Ibb and Taiz (Table 4).
Figure 2 shows the minimum spanning TCS haplotype
network for S. mansoni. The network consisted of four
linked groups but these were not divided by location,
therefore there was no population structure observed
between different areas. At a geographical level, the
minimum spanning TCS network of S. mansoni is
shown in Fig. 3. The S. mansoni haplotypes from the
Yemen provinces connected closely to 3 of the 6 geo-
graphical groups found by Webster et al. [15]. These
haplotypes connected groups 4 (Coastal Kenya and
Zambia), 5 (Zambia ZA2), and 2 (Nigeria, Niger and
Central Africa) which were connected to Group 1 (Far
West Africa, Egypt, Saudi Arabia and Oman). On the
other hand, none of the Yemeni haplotypes occurred
among Group 3 (East Africa) and Group 6 (Zambia
ZA1). Haplotypes found within Ibb province had the
highest diversity and were found in 3 of the groups and
the Taiz province haplotype (Y7TSM) also provided an-
other link with Group 1.
Schistosoma mansoni phylogenetic structuring
The S. mansoni haplotypes clustered into four groups
that correlated to the haplotype network groups, with a
clear separation of group 2 from the rest of the haplo-
types (Fig. 4). This was also highlighted in the net nu-
cleotide divergence between the groups showing a
Table 4 S. mansoni cox1 diversity







Yemen (all) Hap_(1–19) - 100 (31) 0.959 ± 0.018 0.02398
Ibb Y1ISM KP294288 6.7 (1) 0.952 ± 0.040 0.01858
Y6ISM KP294293 6.7 (1)
Y9ISM KP294296 6.7 (1)
Y10ISM KP294297 6.7 (1)
Y11ISM KP294298 6.7 (1)
Y12ISM KP294299 13.3 (2)
Y13ISM KP294300 20 (3)
Y14ISM KP294301 6.7 (1)
Y15ISM KP294302 6.7 (1)
Y16ISM KP294303 6.7 (1)
Y17ISM KP294304 13.3 (2)
Taiz Y4TSM KP294291 11.1 (1) 0.778 ± 0.110 0.00504
Y5TSM KP294292 22.2 (2)
Y7TSM KP294294 44.4 (4)
Y8TSM KP294295 22.2 (2)
Dhamar Y2DSM KP294289 80 (4) 0.400 ± 0.237 0.01513
Y19DSM KP294306 20 (1)
Sana’a Y18SSM KP294305 100 (1) 0 0
Hodiedah Y3HSM KP294290 100 (1) 0 0
n = number of samples with that haplotype
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relatively low genetic separation of the Ibb, Taiz and
Hodiedah lineages (groups 1, 4 and 5) compared to the
larger divergence found in the Sana’a and Dhamar line-
ages (Group 2) (Table 5).
Schistosoma haematobium population genetics
As the schistosome DNA was extracted and amplified
from whole urine samples the DNA sequences repre-
sented the genetic profile from a pooled S. haematobium
population infecting each individual host. Mixed se-
quence chromatograms were observed in only 2 of the
sequences indicating that the haplotypes give a good
representation of the diversity found within the S. hae-
matobium populations. From the five provinces, 9
unique S. haematobium cox1 haplotypes were detected
within the 78 amplified samples. Diversity was low
within and between localities and there was one domin-
ant haplotype (Y2TDISH), which was detected in three
out of the 5 provinces, namely Taiz, Dhamar and Ibb
(Y2TSH, Y2DSH and Y2ISH), representing 29.5 % of the
total haplotypes observed (Table 6). The rest of the hap-
lotypes were unique for their location, with higher diver-
sity being observed in Dhamar and Hodiedah.
Figure 5 shows the minimum spanning TCS network
representing putative genealogy of the haplotypes at a
locality level. The haplotypes divided into two groups.
The first group (Group 1) was made up of 3 haplotypes
all from Hodiedah while the second group (Group 2)
was made up of 6 haplotypes from Taiz, Sana’a, Dhamar
and Ibb. Both groups were linked via a long branch with
several steps connecting the 2 haplotype groups. When
the Yemen haplotypes were analysed together with the S.
haematobium cox1 haplotype data from Webster et al.
[22] the haplotypes were integrated into the 2 groups
(Fig. 6). The most common haplotype found in Yemen
grouped with the haplotypes found in Madagascar,
Mauritius, Zanzibar and Coastal Kenya whilst 1 haplo-
type from Hodiedah matched the dominant mainland
African haplotype H1. Five of the haplotypes from
Yemen were also novel haplotypes which were not re-
ported previously, 2 of which (Y1DSH and Y4HSH) ac-
tually formed a connection between the 2 groups.
Schistosoma haematobium phylogenetic structuring
The tree topology supported the clustering of the 9
Yemen haplotypes into the two S. haematobium groups
with the predominant haplotype (Y2TDISH) clustering
within Group 2 together with haplotypes from Taiz, Ibb,
Dhamar and Sana’a provinces, whereas the haplotypes
from Hodiedah clustered with the Group 1 (Fig. 7). The
net nucleotide divergence 0.01621 ± 0.00500 between the
two S. haematobium groups was low compared to that be-
tween S. haematobium and is sister taxa S. bovis. (Group
1: 0.13252 ± 0.04940; Group 2: 0.12605 ± 0.05946).
Neutrality and selection test
In this study a test for selection reinforced neutrality
within the cox1 mitochondrial data. Tajima’s D test and
McDonald-Kreitman test results showed that strong se-
lection was not occurring in either S. mansoni (Tajima’s
D = 0.702; P > 0.10; Fisher’s exact test P = 0. 978) or S.
Fig. 2 Minimum spanning TCS networks incorporating all 19 S. mansoni cox1 haplotypes from Yemen. Each line between haplotypes represents a
single bp change and small circles between lines represent unsampled or extinct haplotypes. Group 1: Taiz (YTSM) & Ibb (YISM); Group 2: Sana’a
(YSSM) & Dhamar (YDSM); Group 4: Ibb (YISM) Group 5: Ibb (YISM), Hodiedah (YHSM) & Dhamar (YDSM). Grouping of haplotypes was based on
Webster et al. [15]
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haematobium (Tajima’s D = 0.747; P > 0.10; Fisher’s exact
test P = 0.490).
Discussion
Here we present the first genetic data on human Schisto-
soma species in Yemen. Schistosomiasis is still highly
prevalent among children in rural Yemen [28] and
31.8 % of our cohort were infected with Schistosoma
species. Out of these infected children, 122 (96.1 %)
were found to be infected by either S. mansoni or S. hae-
matobium while 5 (3.9 %) children were co-infected with
both species. The overall prevalence was 23.8 % for S.
haematobium and 9.3 % for S. mansoni. The highest
overall prevalence of schistosomiasis was reported in
Hodiedah province, followed by Taiz, while Dhamar had
the lowest prevalence. Hodiedah had the highest preva-
lence of S. haematobium, while Ibb had the highest
prevalence of S. mansoni.
We used conventional PCR to amplify the partial mt
cox1 DNA region of S. haematobium and S. mansoni
DNA extracted from stool and urine samples. The
success rate using the PCR method to amplify Schisto-
soma DNA was 82.6 %, with some false negative reac-
tions being attributed to errors in removing inhibitors
from the samples. Moreover, additional processing re-
quired for the stool kit may also contribute to the low
sensitivity of PCR when compared to microscopy. In the
case of S. haematobium, this success rate was signifi-
cantly associated with the number of eggs in the samples
while no such association was found with S. mansoni.
From 31 S. mansoni PCR positive samples from 5
provinces, we obtained 19 unique and diverse haplo-
types that divided into 4 lineages. These haplotypes
give a good representation of S. mansoni diversity in
Yemen however due to them being obtained from
pooled samples there is more diversity yet to charac-
terise. These 19 haplotypes integrated into groups 1,
2, 4 and 5 based on studies by Webster et al. [15]
and Morgan et al. [21]. Of note, phylogenetic support
was lower in some groups (1 and 4) when compared
with previous reports. This may be due to the high
number of haplotypes reported in this present study,
Fig. 3 Minimum spanning TCS networks joining the 19 S. mansoni cox1 Yemeni haplotypes from this study with other haplotypes from 14
countries within sub-Saharan Africa from Webster et al. [15]. Each line between haplotypes represents a single bp change and small circles
between lines represent unsampled or extinct haplotypes. Connecting group 6 with group 4 was done based on a connection limit of 20–30
nucleotide differences. Majority of Yemeni isolates were grouped closely to coastal Kenya and Zambia (group 4) while five haplotypes were
linked with more complicated network to Niger, Saudi Arabia, Senegal, Mali, Oman, Egypt and Kenya (group 1). Four haplotypes divided equally
between Zambia ZA2 (group 5) and central Africa, Cameron, Niger and Nigeria (group 2). Yemeni haplotypes linked African haplotypes with long
branches within four groups
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and because of the use of a smaller cox1 DNA region
(375 bp) being analysed in this study which decreases
the number of parsimony informative positions. The
larger the mt region used, the more haplotypes would
be detected, but the geographic topologies of the data
would remain the same [15]. Previous cox1 analyses of
S. mansoni samples from across Africa have detected a
high degree of genetic diversity within and between
hosts and localities. Morgan et al. [21] discovered 85
unique haplotypes split into five lineages within 53 geo-
graphically widespread localities and Webster et al. [15]
discovered 120 unique haplotypes split into five distinct
lineages from 54 countries across South America, Africa
and the Arabian Peninsula. Although lower numbers of S.
mansoni samples were analysed from Yemen, the genetic
diversity among S. mansoni haplotypes remained high
strongly supporting the finding by Webster et al. [15] and
Morgan et al. [21].
The TCS network and phylogenetic analysis show the
high diversity of haplotypes that divided into 4 groups /
lineages. The long connections between the main group
(Group 1) and other groups were separated by nodes in
the TCS network and were not represented by a detected
genotype. This suggests that there are still more un-
sampled haplotypes within and between the provinces.
TCS analysis showed that central nodes were connected
with other haplotypes, creating star like assemblages to
form ancestral haplotypes, which were extensively abun-
dant and widely distributed as suggested by Webster et
al. [15]. In the current study, the ancestral haplotypes
were found in Taiz and Ibb provinces in which, perhaps,
the parasites spread to other provinces. Moreover, the
Table 5 Matrices of net evolutionary divergence (Dxy), between the 5 groups/lineages found in the phylogenetic analysis of S.
mansoni haplotypes and the out-group sister species S. rodhaini ± standard deviation
Groups G1 G2 G4 G5
G1 - - - -
G2 0.03872 ± 0.01497 - - -
G4 0.03101 ± 0.00737 0.04216 ± 0.01250 - -
G5 0.01514 ± 0.00544 0.04108 ± 0.01665 0.02771 ± 0.00722 -
S. rodhaini 0.14218 ± 0.05692 0.14665 ± 0.07335 0.15733 ± 0.05210 0.13923 ± 0.06042
Fig. 4 Neighbor-joining cox1 phylogenetic tree for S. mansoni with 1000 bootstrap values. Nineteen haplotypes clustered into five groups
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highest genetic diversity was found among Ibb haplo-
types, which were mostly distributed in Group 4, though
Y6ISM was present in Group 1.
On the other hand, the genetic diversity of S. mansoni
was found to be very low in Sana’a, Dhamar and Hodiedah
probably attributed to the low prevalence of the S.
mansoni in these provinces. The only haplotype of Hodie-
dah, found within Group 5, was linked with Dhamar hap-
lotypes. Likewise, Ibb haplotypes linked the main ancestral
haplotypes from Taiz within Group 1 with haplotypes of
other provinces that showed lower genetic diversity. This
is probably due to Ibb province being geographically con-
nected with Taiz, Hodiedah and Dhamar provinces. It is
important to mention that among the Yemeni population,
Taiz and Ibb populations have the highest migration rate
of people moving either to other Yemen provinces or
other countries. These would suggest that Taiz and Ibb
provinces are likely to be the origin of S. mansoni in
Yemen due to the high genetic diversity found within
those areas.
The net divergence between the lineages revealed a
relatively short time span between the genetic separation
of the Taiz, Ibb and Hodiedah (1, 4 and 5) lineages when
compared to the larger divergence of lineage 2 consisting
of Sana’a and Dhamar isolates. Moreover, the phylogen-
etic analysis showed a strong bootstrap for lineage 4,
which involved Sana’a and Dhamar haplotypes, via a
long branch from lineage 1. That said, there has been a
long time between the separation of the haplotypes of
Sana’a and Dhamar from the rest of the S. mansoni
population, with successive splitting of populations
within Ibb haplotypes in lineage 5. This may be attrib-
uted to population, movement, which carried those hap-
lotypes between provinces, stating from Taiz to Ibb, then
to Dhamar and ending with Sana’a province.
The results of the present study were incorporated
with the results of the previous large-scale studies con-
ducted on isolates from across Africa and also from the
Arabian Peninsula and the Neotropic ecozone [15, 19].
Interestingly, for S. mansoni, our findings show that
Yemen has a higher genetic diversity than Tanzania,
Fig. 5 Minimum spanning TCS networks incorporating all 9 S.
haematobium cox1 haplotypes from Yemen. Each line between
haplotypes represents a single bp change and small circles
between lines represent unsampled or extinct haplotypes. The
network forms 2 groups of haplotypes linked together. Group 1
forms one branch containing only samples from Hodiedah (YHSH).
Group 2 forms simple network containing Taiz (YTSH), Dhamar (YDSH),
Sana’a (YSSH) and Ibb (YISH). The majority of the samples are closely
clustered around the main haplotype (Y2TDISH) with separate single
links representing a single polymorphic mutation
Table 6 S. haematobium cox1 diversity







Yemen (all) h (1–9) - 100 (78) 0.819 ± 0.022 0.00911
Dhamar Y1DSH KP294279 30.8 (4) 0.641 ± 0.097 0.00143
Y2DSH (Y2TDISH) KP294280 53.8 (7)
Y3DSH KP294281 15.4 (2)
Hodiedah Y4HSH KP294282 15.4 (4) 0.615 ± 0.063 0.00252
Y5HSH KP294283 30.8 (8)
Y6HSH KP294284 53.8 (14)
Taiz Y2TSH (Y2TDISH) KP294280 78.9 (15) 0.351 ± 0.111 0.00068
Y9TSH KP294287 21.1 (4)
Sana’a Y7SSH KP294285 5.3 (1) 0.105 ± 0.092 0.00020
Y8SSH KP294286 94.7 (18)
Ibb Y2ISH (Y2TDISH) KP294280 100 (1) 0 0
n = number of samples that had the same haplotype. Y2TDISH is the common haplotype found between regions
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Zambia and Coastal Kenya, which suggests that S. man-
soni was first introduced in East Africa before spreading
to Central and West Africa with subsequent splitting of
populations. This is in accordance with a previous pos-
tulation that African S. mansoni evolutionary origin was
in East Africa [21]. However, these speculations need
further investigation as historical human migrations
between Africa and Arabian Peninsula may have oc-
curred continuously and reciprocally.
The regional TCS network for S. mansoni (Fig. 3) shows
the isolates from Yemen may well bridge the gap between
the African lineages. On the basis of this TCS network,
one may speculate that Ibb haplotypes were probably in-
troduced to Zambia and coastal Kenya (Group 4). On the
Fig. 6 Minimum spanning TCS networks joining the 9 S. haematobium cox1 Yemeni haplotypes by this study and 18 countries across Africa and
the Indian Ocean Islands from by Webster et al. [15, 22]. Each line between haplotypes represents a single bp change and small circles between
lines represent unsampled or extinct haplotypes. H1 involved haplotypes from SE1, SE2a, SE3a, SE4, SE5, SE6a, SE7a, SE8a, SE9, MA2, NI1a, NI2, LB1,
GB1, NG1, CA1, CA1a, CA2, CA3, CA4, CA5, SU1, KE2, TA1a, MW1, MW2a, MW3 & Zan4. Hodiedah haplotypes were exclusively linked with group 1
and Y5HSH was found similar to H1. The rest of Yemeni haplotypes were grouped with coastal Kenya, Zanzibar, Tanzania, Mauritius & Madagascar.
Y2TDISH include Y2DSH, Y2TSH & Y2ISH haplotypes (group 2). Yemeni haplotypes linked the two groups of African haplotypes with small branches
Fig. 7 Neighbor-joining phylogenetic tree for S. haematobium with 1000 bootstrap values. Y2TDISH was the dominant haplotype detected in
three provinces, Taiz (Y2TSH), Dhamar (Y2DSH), and Ibb (Y2ISH)
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other hand, other Ibb haplotypes (Group 1) were most
probably moved to either Nigeria through a long branch
to Central West Africa (Group 2), or Niger by a link to far
West Africa (Group 1). In addition, Taiz haplotypes with a
high genetic diversity were most properly moved to Saudi
Arabia, which then links to both Brazil and Egypt.
With regard to S. haematobium, the present study
shows that the genetic diversity of S. haematobium was
low across Yemen, supporting the findings by Webster et
al. [19] who revealed low levels of genetic diversity among
61 unique haplotypes from across Africa. In the 78 posi-
tive urine samples, we found only 9 unique haplotypes,
which were divided into two groups. Group 2 involved 4
provinces, namely Sana’a, Taiz, Ibb and Dhamar, with
Y2TDISH being the predominant haplotype. Whilst
Group 1 exclusively involved haplotypes from Hodiedah.
The net divergence between the two groups was similar to
that previously reported in Webster et al. [19].
The TCS network shows that the predominant haplo-
type (Y2TDISH) was linked by a single bp change with
other haplotypes from Taiz, Sana’a and two haplotypes
from Dhamar, which connected Group 1 with Group 2.
The majority of those haplotypes branched off from
Y2TDISH by single mutations, although their clear links
with other haplotypes suggest that they persist within
the populations and disseminate from one area to an-
other due to population movement. The network discov-
ered around the predominant haplotype reflected the
geographical links between the 4 provinces in Group 2,
as well as the extensive movement of populations be-
tween those provinces. This TCS network suggests that
Dhamar may be the origin of S. haematobium in Yemen,
as this had the highest genetic diversity of all the prov-
inces studied. However, this may need further investiga-
tion using more isolates including other provinces which
were not included in the current study.
The divergence of the S. haematobium populations be-
tween the 2 groups might be affected by the compatibility
with their intermediate snail hosts (Bulinus spp.), which
are specific and varied according to geographical location
[42, 43]. However, there have been no studies on the inter-
mediate host of S. haematobium in Yemen, necessitating
future research to elucidate the role of Bulinus species in
the transmission of S. haematobium in Yemen.
The genetic diversity of S. haematobium in Yemen
was considered high when compared with the low diver-
sity across Africa, but not higher than the Indian Islands,
and coastal Kenya regions [19]. The low genetic diversity
reported across Africa was possibly attributed to a re-
invasion by a small population of S. haematobium that
originated as part of a larger population group from Asia
across the Arabian Peninsula, with fast distribution and
growth from East to West through Africa [19, 44]. Due
to parasitic inbreeding, the worms are incompatible with
the new genetic flow across Africa. While the TCS net-
work created by Webster et al. [19] formed two distinct
groups of S. haematobium haplotypes that cannot be
linked, the TCS network generated by the present study
shows Yemen haplotypes bridging the gap and connect-
ing both groups, namely Group 1 (mainland Africa with
few haplotypes from Zanzibar) and Group 2 (the Indian
Ocean islands and the neighbouring African coastal re-
gions of coastal Kenya and Tanzania) (Fig. 6). However,
this will be a direct affect of the smaller DNA region
used in the analysis which reduces the polymorphisms
between the groups bringing them genetically closer.
This highly associated haplotype network between
Yemen and Africa may be explained by the numerous
commercial Yemeni traders trips that took place when
sailors were using the monsoon winds to sail across the
Indian Ocean, at which time they landed at the sheltered
harbour located on the site of present-day Zanzibar
Town in Tanzania. Although the islands had few re-
sources of interest to the traders, they offered a good lo-
cation from which to make contact and trade with
towns of the East African coast. Nowadays, population
movement between Yemen and East Africa including
Kenya, Tanzania and Ethiopia is still very active. Another
factor could be the annual Islamic pilgrimage that in-
volved the travelling of people from all over the world to
the Arabian Peninsula, specifically to Mecca. Although
Mecca has an arid climate, which does not favour the
transmission of schistosomiasis, the pilgrims would often
cross through Yemen and other northern parts of the
peninsula where schistosomiaisis was endemic.
This conjecture is supported by the discovery of the
oldest ever urogenital Schistosoma egg in 6200-year-old
human skeletal remains at a prehistoric town (Tell Zeidan)
by the Euphrates river valley in northern Syria [45].
Moreover, modern genetic analysis suggests that the genus
Schistosoma originally evolved in Asia and then spread to
Africa [44]. There are a few theories on the origin of
Schistosoma, with primary arguments being for both an
African and Asian origin [46–48]. Davis [46] proposed that
the genus Schistosoma arose before the separation of the
super continent Gondwanaland more than 150 million
years ago, with the earliest known archaeological examples
coming from ancient Egyptian mummies and Syrian graves
dated 5200 and 6500 years old respectively [45, 49].
In 2008, Yemen launched its first campaign to elimin-
ate schistosomiasis as a national public health problem,
with the aim of controlling schistosomiasis nationwide
and eliminating its morbidity. This campaign was waged
through repeated periodic (often yearly) distribution of
PZQ to targeted population in schools and communities,
together with the dissemination of health education
messages on schistosomiasis [25]. Although PZQ has
been used effectively for about three decades, the
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reliance of schistosomiasis control programmes on
PZQ only makes the control of this disease highly
vulnerable to the emergence and spread of drug re-
sistant strains [9]. This might be anticipated due to
drug pressure leading to intensive and prolonged new
selection pressures on the parasites, which may in
turn affect the genotypic and phenotypic structure of
a parasite population in a controlled setting resulting
in a decline in diversity over time to a few persistent
genotypes [50, 51]. Non-susceptible survival genotypes
with reduction of diversity were reported in a labora-
tory population [51, 52] and also among travellers in
Egypt, Senegal and Mali [8, 53–55]. Furthermore, pre-
vious experience with oxamaniquine, which was in
wide use prior to the development and use of PZQ,
revealed the ability of schistosome parasites to de-
velop drug resistance under field conditions [56, 57].
Hence, evolutionary theory must play a role both in the
monitoring, evaluation, and importantly in predicting the
sustained impact of these control programmes.
Conclusion
The findings of the present study have brought new
insight into the population genetics of human Schisto-
soma species across Yemen. In particular, the genetic di-
versity of S. mansoni was found to be high while S.
haematobium showed low diversity. This data was ob-
tained from pooled schistosome DNA from whole urine
and stool samples. Therefore, by adapting the methods
used by Webster et al. [19] which described obtaining
the haplotype data from individual miracidia, the true
extent of the diversity within and between Schistosoma
populations can be fully assessed in future studies. Data
compiled in order to identify genetic diversity as reported
by this study, and in comparison with previous studies, may
have a value in monitoring changes in schistosome popula-
tions over time, in response to control pressure and due to
environmental changes or migration of hosts. The genetic
analysis of more individual schistosome larval stages,
together with investigations into intermediate host snails
from different endemic areas in Yemen and other countries
in the Arabian Peninsula, using other mitochondrial genes
and microsatellite markers is still required in order to
interpret the true genetic diversity, population movement
and dynamics of transmission for S. mansoni and S.
haematobium populations on a large scale.
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